Cyclo Therapeutics Inc.

NASDAQ: CYTH · Real-Time Price · USD
0.72
-0.00 (-0.08%)
At close: Mar 25, 2025, 3:59 PM

Cyclo Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.29 -0.78 -1.66
PEG Ratio
0.04 0.04 0.03
PS Ratio
24.12 8.71 14.98
PB Ratio
5.46 16.31 1.52
P/FCF Ratio
-1.6 -0.79 -1.58
P/OCF Ratio
-1.6 -0.79 -1.58
OCF/S Ratio
-15.04 -10.99 -9.46
Debt / Equity Ratio
0.22 n/a 0.01
Quick Ratio
1.42 1.12 5.01
Current Ratio
1.45 1.19 5.07
Asset Turnover
0.08 0.33 0.08
Interest Coverage
n/a n/a n/a
Return on Equity
-4.22 -20.8 -0.91
Return on Assets
-1.51 -3.62 -0.73
Return on Invested Capital
-3.46 -21.02 -0.9
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
0.91 0.90 0.90
Net Profit Margin
-18.63 -11.11 -9.02
Pretax Profit Margin
-18.63 -11.23 -9.01
Operating Profit Margin
-18.63 -11.35 -9
FCF Margin
n/a n/a n/a
EBITDA Margin
-18.61 -11.34 -9